Bristol Myers Squibb Buys Nvidia DGX SuperPOD for Drug Discovery
Bristol Myers Squibb Buys Nvidia DGX SuperPOD for Drug Discovery
FAQ
What is Nvidia's DGX SuperPOD?
It's an integrated supercomputing system designed for large-scale AI workloads, based on the new Vera Rubin architecture.
How will Bristol Myers Squibb use this system?
It will use the system to accelerate drug discovery and development by analyzing large datasets and training AI models.
Is this deal relevant for the MENA region?
Yes, it highlights the global trend of AI in pharma, encouraging regional companies to adopt similar technologies.
Source: Artificial Intelligence News
AI-assisted content, human-reviewed.